325 related articles for article (PubMed ID: 19843668)
1. An admixture scan in 1,484 African American women with breast cancer.
Fejerman L; Haiman CA; Reich D; Tandon A; Deo RC; John EM; Ingles SA; Ambrosone CB; Bovbjerg DH; Jandorf LH; Davis W; Ciupak G; Whittemore AS; Press MF; Ursin G; Bernstein L; Huntsman S; Henderson BE; Ziv E; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3110-7. PubMed ID: 19843668
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility loci for subtypes of breast cancer in an African American population.
Palmer JR; Ruiz-Narvaez EA; Rotimi CN; Cupples LA; Cozier YC; Adams-Campbell LL; Rosenberg L
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):127-34. PubMed ID: 23136140
[TBL] [Abstract][Full Text] [Related]
3. Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among Black and White women.
Reding KW; Carlson CS; Kahsai O; Chen CC; McDavid A; Doody DR; Chen C; Ornelas I; Lowe K; Bernstein L; Weiss L; McDonald JA; Simon MS; Strom B; Marchbanks PA; Burkman R; Spirtas R; Liff JM; Malone KE
Breast Cancer Res Treat; 2012 Jul; 134(2):801-9. PubMed ID: 22648732
[TBL] [Abstract][Full Text] [Related]
4. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
[TBL] [Abstract][Full Text] [Related]
5. Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.
Quan L; Gong Z; Yao S; Bandera EV; Zirpoli G; Hwang H; Roberts M; Ciupak G; Davis W; Sucheston L; Pawlish K; Bovbjerg DH; Jandorf L; Cabasag C; Coignet JG; Ambrosone CB; Hong CC
Int J Cancer; 2014 Mar; 134(6):1408-21. PubMed ID: 23996684
[TBL] [Abstract][Full Text] [Related]
6. Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium.
Luyeye Mvila G; Batalansi D; Praet M; Marchal G; Laenen A; Christiaens MR; Brouckaert O; Ali-Risasi C; Neven P; Van Ongeval C
Breast; 2015 Oct; 24(5):642-8. PubMed ID: 26279132
[TBL] [Abstract][Full Text] [Related]
7. Variants of estrogen-related genes and breast cancer risk in European and African American women.
Quan L; Hong CC; Zirpoli G; Roberts MR; Khoury T; Sucheston-Campbell LE; Bovbjerg DH; Jandorf L; Pawlish K; Ciupak G; Davis W; Bandera EV; Ambrosone CB; Yao S
Endocr Relat Cancer; 2014; 21(6):853-64. PubMed ID: 25228414
[TBL] [Abstract][Full Text] [Related]
8. An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer.
Zhu B; Mukherjee A; Machiela MJ; Song L; Hua X; Shi J; Garcia-Closas M; Chanock SJ; Chatterjee N
Br J Cancer; 2016 Sep; 115(6):752-60. PubMed ID: 27467053
[TBL] [Abstract][Full Text] [Related]
9. MYC amplification in subtypes of breast cancers in African American women.
Naab TJ; Gautam A; Ricks-Santi L; Esnakula AK; Kanaan YM; DeWitty RL; Asgedom G; Makambi KH; Abawi M; Blancato JK
BMC Cancer; 2018 Mar; 18(1):274. PubMed ID: 29523126
[TBL] [Abstract][Full Text] [Related]
10. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.
Haiman CA; Chen GK; Vachon CM; Canzian F; Dunning A; Millikan RC; Wang X; Ademuyiwa F; Ahmed S; Ambrosone CB; Baglietto L; Balleine R; Bandera EV; Beckmann MW; Berg CD; Bernstein L; Blomqvist C; Blot WJ; Brauch H; Buring JE; Carey LA; Carpenter JE; Chang-Claude J; Chanock SJ; Chasman DI; Clarke CL; Cox A; Cross SS; Deming SL; Diasio RB; Dimopoulos AM; Driver WR; Dünnebier T; Durcan L; Eccles D; Edlund CK; Ekici AB; Fasching PA; Feigelson HS; Flesch-Janys D; Fostira F; Försti A; Fountzilas G; Gerty SM; ; Giles GG; Godwin AK; Goodfellow P; Graham N; Greco D; Hamann U; Hankinson SE; Hartmann A; Hein R; Heinz J; Holbrook A; Hoover RN; Hu JJ; Hunter DJ; Ingles SA; Irwanto A; Ivanovich J; John EM; Johnson N; Jukkola-Vuorinen A; Kaaks R; Ko YD; Kolonel LN; Konstantopoulou I; Kosma VM; Kulkarni S; Lambrechts D; Lee AM; Marchand LL; Lesnick T; Liu J; Lindstrom S; Mannermaa A; Margolin S; Martin NG; Miron P; Montgomery GW; Nevanlinna H; Nickels S; Nyante S; Olswold C; Palmer J; Pathak H; Pectasides D; Perou CM; Peto J; Pharoah PD; Pooler LC; Press MF; Pylkäs K; Rebbeck TR; Rodriguez-Gil JL; Rosenberg L; Ross E; Rüdiger T; Silva Idos S; Sawyer E; Schmidt MK; Schulz-Wendtland R; Schumacher F; Severi G; Sheng X; Signorello LB; Sinn HP; Stevens KN; Southey MC; Tapper WJ; Tomlinson I; Hogervorst FB; Wauters E; Weaver J; Wildiers H; Winqvist R; Van Den Berg D; Wan P; Xia LY; Yannoukakos D; Zheng W; Ziegler RG; Siddiq A; Slager SL; Stram DO; Easton D; Kraft P; Henderson BE; Couch FJ
Nat Genet; 2011 Oct; 43(12):1210-4. PubMed ID: 22037553
[TBL] [Abstract][Full Text] [Related]
11. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC
JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.
Huo D; Feng Y; Haddad S; Zheng Y; Yao S; Han YJ; Ogundiran TO; Adebamowo C; Ojengbede O; Falusi AG; Zheng W; Blot W; Cai Q; Signorello L; John EM; Bernstein L; Hu JJ; Ziegler RG; Nyante S; Bandera EV; Ingles SA; Press MF; Deming SL; Rodriguez-Gil JL; Nathanson KL; Domchek SM; Rebbeck TR; Ruiz-Narváez EA; Sucheston-Campbell LE; Bensen JT; Simon MS; Hennis A; Nemesure B; Leske MC; Ambs S; Chen LS; Qian F; Gamazon ER; Lunetta KL; Cox NJ; Chanock SJ; Kolonel LN; Olshan AF; Ambrosone CB; Olopade OI; Palmer JR; Haiman CA
Hum Mol Genet; 2016 Nov; 25(21):4835-4846. PubMed ID: 28171663
[TBL] [Abstract][Full Text] [Related]
13. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.
Dunnwald LK; Rossing MA; Li CI
Breast Cancer Res; 2007; 9(1):R6. PubMed ID: 17239243
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry.
Ambrosone CB; Young AC; Sucheston LE; Wang D; Yan L; Liu S; Tang L; Hu Q; Freudenheim JL; Shields PG; Morrison CD; Demissie K; Higgins MJ
Oncotarget; 2014 Jan; 5(1):237-48. PubMed ID: 24368439
[TBL] [Abstract][Full Text] [Related]
15. Parity and lactation in relation to estrogen receptor negative breast cancer in African American women.
Palmer JR; Boggs DA; Wise LA; Ambrosone CB; Adams-Campbell LL; Rosenberg L
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1883-91. PubMed ID: 21846820
[TBL] [Abstract][Full Text] [Related]
16. Advanced stages and poorly differentiated grade are associated with an increased risk of HER2/neu positive breast carcinoma only in White women: findings from a prospective cohort study of African-American and White-American women.
Stark A; Kapke A; Schultz D; Brown R; Linden M; Raju U
Breast Cancer Res Treat; 2008 Feb; 107(3):405-14. PubMed ID: 17431759
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women.
Rosenberg L; Boggs DA; Wise LA; Adams-Campbell LL; Palmer JR
Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2073-9. PubMed ID: 20647407
[TBL] [Abstract][Full Text] [Related]
18. An exome-wide analysis of low frequency and rare variants in relation to risk of breast cancer in African American Women: the AMBER Consortium.
Haddad SA; Ruiz-Narváez EA; Haiman CA; Sucheston-Campbell LE; Bensen JT; Zhu Q; Liu S; Yao S; Bandera EV; Rosenberg L; Olshan AF; Ambrosone CB; Palmer JR; Lunetta KL
Carcinogenesis; 2016 Sep; 37(9):870-877. PubMed ID: 27267999
[TBL] [Abstract][Full Text] [Related]
19. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women.
Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W
Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715
[TBL] [Abstract][Full Text] [Related]
20. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.
Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
J Surg Res; 2007 Nov; 143(1):109-18. PubMed ID: 17950079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
